BlackRock
BDSX icon

BlackRock’s Biodesix BDSX Stock Holding History

BlackRock’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$970K Buy
43,026
+18,560
+76% +$275K ﹤0.01% 4362
2026
Q1 		$355K Hold
24,466
– – ﹤0.01% 4615
2025
Q4 		$166K Hold
24,466
– – ﹤0.01% 4776
2025
Q3 		$185K Sell
24,466
-1
-0% -$8 ﹤0.01% 4691
2025
Q2 		$138K Sell
24,467
-3,912
-14% -$31.6K ﹤0.01% 4761
2025
Q1 		$355K Sell
28,379
-75
-0.3% -$1.44K ﹤0.01% 4476
2024
Q4 		$871K Buy
28,454
+25
+0.1% +$736 ﹤0.01% 4255
2024
Q3 		$1.01M Buy
28,429
+7,634
+37% +$263K ﹤0.01% 4170
2024
Q2 		$636K Buy
20,795
+650
+3% +$18.6K ﹤0.01% 4282
2024
Q1 		$576K Sell
20,145
-78
-0.4% -$2.67K ﹤0.01% 4336
2023
Q4 		$744K Buy
20,223
+207
+1% +$6.5K ﹤0.01% 4334
2023
Q3 		$661K Sell
20,016
-456
-2% -$12.7K ﹤0.01% 4347
2023
Q2 		$504K Buy
20,472
+470
+2% +$14.1K ﹤0.01% 4483
2023
Q1 		$744K Buy
20,002
+17,996
+897% +$739K ﹤0.01% 4430
2022
Q4 		$92.3K Buy
2,006
+41
+2% +$1.11K ﹤0.01% 5067
2022
Q3 		$50K Buy
1,965
+103
+6% +$3.97K ﹤0.01% 5349
2022
Q2 		$61K Sell
1,862
-26,618
-93% -$865K ﹤0.01% 5372
2022
Q1 		$962K Sell
28,480
-382
-1% -$25K ﹤0.01% 4678
2021
Q4 		$3.05M Buy
28,862
+303
+1% +$39.6K ﹤0.01% 4218
2021
Q3 		$4.7M Sell
28,559
-128
-0.4% -$24.3K ﹤0.01% 3988
2021
Q2 		$7.58M Buy
28,687
+20,692
+259% +$6.5M ﹤0.01% 3746
2021
Q1 		$3.25M Buy
7,995
+4,629
+138% +$2.07M ﹤0.01% 4130
2020
Q4 		$1.36M Buy
+3,366
New +$1.05M ﹤0.01% 4141

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock's BDSX Position: Q2 2026 in Review

BlackRock increased its Biodesix (BDSX) stake by 76% in Q2 2026, buying an estimated $275K and bringing the position to 43,026 shares worth $970K. The position accounts for ﹤0.01% of the portfolio, ranked #4362.

BlackRock first reported a position in BDSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.58M in Q2 2021. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • BlackRock held 43,026 shares of Biodesix worth $970K as of Q2 2026.
  • BlackRock bought 18,560 Biodesix shares in Q2 2026, an estimated $275K.
  • Biodesix made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4362 holding.
  • BlackRock first reported a position in Biodesix in Q4 2020 and has held it in 23 quarters since.
  • BlackRock's Biodesix position peaked at $7.58M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.